Now showing items 41-60 of 183

    Issue DateTitleAuthor(s)
    13 December 2021Analysis of CYP2C19 genetic variants with ischaemic events in UK patients prescribed clopidogrel in primary care: a retrospective cohort study.  Pilling, LC; Türkmen, D; Fullalove, H; et al.
    12 January 2018Analysis of DNA Methylation in Young People: Limited Evidence for an Association Between Victimization Stress and Epigenetic Variation in Blood  Marzi, SJ; Sugden, K; Arsenault, L; et al.
    1 August 2017Analysis of large-scale sequencing cohorts does not support the role of variants in UCP2 as a cause of hyperinsulinaemic hypoglycaemia.  Laver, TW; Weedon, MN; Caswell, R; et al.
    1 October 2019Analysis of lifetime mortality trajectories in wildlife disease research: BaSTA and Beyond  Hudson, DW; Delahay, R; McDonald, RA; et al.
    7 January 2014Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man  Flanagan, SE; De Franco, E; Lango Allen, H; et al.
    3 September 2019Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer  Munkley, J; Ling, L; Krishnan, SRG; et al.
    5 November 2018Angiotensin II-induced hypertension in rats is only transiently accompanied by lower renal oxygenation  Emans, TW; Patinha, D; Joles, JA; et al.
    12 July 2017ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity  Mastroeni, D; Sekar, S; Nolz, J; et al.
    2 October 2014Another explanation for apparent epistasis  Wood, AR; Tuke, MA; Nalls, MA; et al.
    19 March 2013Ant Colony Optimisation for Exploring Logical Gene-Gene Associations in Genome Wide Association Studies  Sapin, E; Keedwell, E; Frayling, TM
    1 November 2015An Ant Colony Optimization and Tabu List Approach to the Detection of Gene-Gene Interactions in Genome-Wide Association Studies [Research Frontier]  Sapin, E; Keedwell, E; Frayling, T
    16 November 2018Anti-angiogenic isoform of vascular endothelial growth factor-A in cardiovascular and renal disease  Kikuchi, R; Stevens, M; Harada, K; et al.
    14 July 2016Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status  Cameron, AR; Morrison, V; Levin, D; et al.
    16 March 2022Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab  Lin, S; Kennedy, NA; Saifuddin, A; et al.
    18 May 2020Antifungal activity of antimicrobial peptides and proteins against Aspergillus fumigatus  Ballard, E; Yucel, R; Melchers, WJG; et al.
    13 June 2022Antifungal Exposure and Resistance Development: Defining Minimal Selective Antifungal Concentrations and Testing Methodologies  Stevenson, EM; Gaze, WH; Gow, NAR; et al.
    26 October 2021Antimicrobial resistance acquisition via natural transformation: context is everything  Winter, M; Buckling, A; Harms, K; et al.
    8 December 2016Ap39, A Mitochondria-Targeting Hydrogen Sulfide (H2 s) Donor, Protects Against Myocardial Reperfusion Injury Independently Of Salvage Kinase Signalling.  Karwi, QG; Bornbaum, J; Boengler, K; et al.
    28 October 2015AP39, A Mitochondrially- Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo.  Ahmad, Akbar; Olah, Gabor; Szczesny, Bartosz; et al.
    19 April 2014AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.  Szczesny, B; Módis, K; Yanagi, K; et al.